Shares of Albemarle Co. (NYSE:ALB) have been given a consensus recommendation of “Buy” by the twenty-three analysts that are currently covering the firm, Marketbeat.com reports. Eleven investment analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $128.00.

ALB has been the subject of a number of analyst reports. Robert W. Baird reaffirmed a “hold” rating and issued a $135.00 target price on shares of Albemarle in a research report on Wednesday, November 1st. Instinet raised their target price on shares of Albemarle from $134.00 to $146.00 and gave the company a “buy” rating in a research report on Monday, September 18th. Jefferies Group raised their target price on shares of Albemarle from $156.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, November 14th. Nomura raised their target price on shares of Albemarle from $146.00 to $154.00 and gave the company a “buy” rating in a research report on Tuesday, October 10th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $149.00 target price on shares of Albemarle in a research report on Wednesday, October 18th.

Institutional investors and hedge funds have recently made changes to their positions in the company. Thompson Davis & CO. Inc. grew its position in shares of Albemarle by 650.0% in the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock valued at $102,000 after acquiring an additional 650 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of Albemarle by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after acquiring an additional 20 shares during the period. Highlander Capital Management LLC bought a new position in shares of Albemarle in the 2nd quarter valued at about $106,000. Howe & Rusling Inc. grew its position in shares of Albemarle by 2,038.0% in the 3rd quarter. Howe & Rusling Inc. now owns 1,069 shares of the specialty chemicals company’s stock valued at $146,000 after acquiring an additional 1,019 shares during the period. Finally, Advisory Services Network LLC grew its position in shares of Albemarle by 43.7% in the 2nd quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock valued at $134,000 after acquiring an additional 387 shares during the period. 87.99% of the stock is owned by institutional investors.

Albemarle (NYSE ALB) traded up $1.50 during trading on Monday, reaching $131.72. 806,520 shares of the company were exchanged, compared to its average volume of 1,060,000. The company has a market capitalization of $14,550.00, a P/E ratio of 47.04, a P/E/G ratio of 1.71 and a beta of 1.69. Albemarle has a 1-year low of $89.09 and a 1-year high of $144.99. The company has a current ratio of 2.11, a quick ratio of 1.56 and a debt-to-equity ratio of 0.35.

Albemarle (NYSE:ALB) last released its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.01. The business had revenue of $755.00 million during the quarter, compared to the consensus estimate of $732.19 million. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. The firm’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 earnings per share. analysts predict that Albemarle will post 4.46 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Friday, December 15th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is presently 45.71%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Marea Informative and is the sole property of of Marea Informative. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.mareainformativa.com/2018/01/29/brokerages-set-albemarle-co-alb-price-target-at-128-00-updated-updated-updated.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.